NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.

NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.

NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.

NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine.

NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.

NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization.

NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease.

NEJM Interview: Michael Liu on a new model that will expand the use of prior authorization in traditional Medicare.

NEJM Interview: Andrew Gabrielson on cuts to the U.S. research agency charged with safeguarding workers’ health.

NEJM Interview: Steven Lipstein on the drivers and the benefits of mergers and consolidation, from the perspective of a health care system leader.

NEJM Interview: Nancy Krieger on the effects of structural racism on health and health care and the conflation of research on health equity with DEI work.

NEJM Interview: John Ayanian on opportunities to study the health and economic effects of Medicaid work requirements and to mitigate their adverse consequences.

NEJM Interview: Darshali Vyas on campaigns to remove race from clinical algorithms.

NEJM Interview: Amanda Janitz on a navigation program aimed at improving cancer outcomes for American Indian and Alaska Native patients.

NEJM Interview: Amitabh Chandra on why corporatization occurs in health care, when it can succeed, and why it can go wrong.

NEJM Interview: Nicholas Bagley on the Supreme Court’s decision in a case with implications for coverage of preventive services.

NEJM Interview: Tom Frieden on the role of the CDC and current threats to the U.S. public health infrastructure.

NEJM Interview: Nancy Tomes on the century-long transition to a corporate business model in U.S. health care.

NEJM Interview: Rohan Khazanchi on the gradual but incomplete shift to race-free equations for interpreting pulmonary function tests.

NEJM Interview: Jason Schwartz on changes to the Advisory Committee on Immunization Practices and approaches to sustaining U.S. vaccination efforts.